EUVIMEDEUVIMED entdecken
Crossref

Inhibition of XPR1‐dependent phosphate efflux induces mitochondrial dysfunction: A potential molecular target therapy for hepatocellular carcinoma?

Zi-Qiang Liao, Yang-Feng Lv, Mei-Diao Kang, Yu-Long Ji, Yue Liu, Le-Ran Wang, Jia-Liang Tang, Zhi-Qiang Deng, Yun Yi, Qun Tang iD

Molecular Carcinogenesis · 2024-12 · 63 (12) · 2332-2345

DOI: 10.1002/mc.23812 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Carcinogenesis, online erschienen am 13.08.2024. Verfasst von Zi-Qiang Liao und 9 weiteren Autor:innen. Beteiligte Einrichtung: The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, College of Pharmacy, Jiangxi Medical College, Nanchang Un…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Xenotropic and Polytropic Retrovirus Receptor, Cell Proliferation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangxi Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Xenotropic and polytropic retrovirus receptor 1 (XPR1) is the only known transporter associated with Pi efflux in mammals, and its impact on tumor progression is gradually being revealed. However, the role of XPR1 in hepatocellular carcinoma (HCC) is unknown. A bioinformatics screen for the phosphate exporter XPR1 was performed in HCC patients. The expression of XPR1 in clinical specimens was analyzed using quantitative real‐time PCR, Western blot analysis, and immunohistochemical assays. Knockdown of the phosphate exporter XPR1 was performed by shRNA transfection to investigate the cellular phenotype and phosphate‐related cytotoxicity of the Huh7 and HLF cell lines. In vivo tests were conducted to investigate the tumorigenicity of HCC cells xenografted into immunocompromised mice after silencing XPR1. Compared with that in paracancerous tissue, XPR1 expression in HCC tissues was markedly upregulated. High XPR1 expression significantly correlated with poor patient survival. Silencing of XPR1 leads to decreased proliferation, migration, invasion, and colony formation in HCC cells. Mechanistically, knockdown of XPR1 causes an increase in intracellular phosphate levels; mitochondrial dysfunction characterized by reduced mitochondrial membrane potential and adenosine triphosphate levels; increased reactive oxygen species levels; abnormal mitochondrial morphology; and downregulation of key mitochondrial fusion, fission, and inner membrane genes. This ultimately results in mitochondria‐dependent apoptosis. These findings reveal the prognostic value of XPR1 in HCC progression and, more importantly, suggest that XPR1 might be a potential therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsXenotropic and Polytropic Retrovirus ReceptorCell ProliferationPhosphatesHumansAnimalsMiceCell Line, TumorMitochondriaMaleGene Expression Regulation, NeoplasticXenograft Model Antitumor AssaysMolecular Targeted TherapyFemaleMice, NudeCell MovementMembrane Potential, MitochondrialApoptosisMiddle AgedReactive Oxygen SpeciesPrognosis

Stichwörter der Autor:innen

XPR1hepatocellular carcinomamitochondrion dysfunctionphosphate transporterprognostic markertherapeutic target

Substanzen

Xenotropic and Polytropic Retrovirus ReceptorXPR1 protein, humanPhosphatesReactive Oxygen Species

Autor:innen und Institutionen

  • The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, College of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • Institute for Advanced Study, Nanchang University, Nanchang, China.
  • School of Public Health, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • Queen Mary School, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • Nanchang No. 2 High School, Nanchang, China.
  • Department of Oncology, The First People's Hospital of Fuzhou, Fuzhou, China.

ORCID-Profile: Qun Tang

Förderung

  • Natural Science Foundation of Jiangxi Province
  • National Natural Science Foundation of China

Zitieren

APA

Liao, Z. Q., Lv, Y. F., Kang, M. D., Ji, Y. L., Liu, Y., Wang, L. R., Tang, J. L., Deng, Z. Q., Yi, Y., & Tang, Q. (2024). Inhibition of XPR1‐dependent phosphate efflux induces mitochondrial dysfunction: A potential molecular target therapy for hepatocellular carcinoma?. Molecular Carcinogenesis, 63(12), 2332-2345. https://doi.org/10.1002/mc.23812

Vancouver

Liao ZQ, Lv YF, Kang MD, Ji YL, Liu Y, Wang LR, et al. Inhibition of XPR1‐dependent phosphate efflux induces mitochondrial dysfunction: A potential molecular target therapy for hepatocellular carcinoma?. Molecular Carcinogenesis. 2024;63(12):2332-2345. doi:10.1002/mc.23812

BibTeX
@article{Liao2024,
  author = {Liao, Zi-Qiang and Lv, Yang-Feng and Kang, Mei-Diao and Ji, Yu-Long and Liu, Yue and Wang, Le-Ran and Tang, Jia-Liang and Deng, Zhi-Qiang and Yi, Yun and Tang, Qun},
  title = {Inhibition of XPR1‐dependent phosphate efflux induces mitochondrial dysfunction: A potential molecular target therapy for hepatocellular carcinoma?},
  journal = {Molecular Carcinogenesis},
  year = {2024},
  volume = {63},
  number = {12},
  pages = {2332--2345},
  doi = {10.1002/mc.23812}
}
Kostenlos starten →